HOME >> BIOLOGY >> NEWS
Surveillance and containment would be effective intervention against deliberate smallpox attack

SEATTLE -- In the event of a large, intentional release of smallpox, the current government policy of post-release surveillance and containment, if quickly implemented, would be sufficient to prevent a widespread epidemic, according to a study by biostatisticians at Emory University's Rollins School of Public Health. Surveillance and containment consist of isolating known cases and vaccinating close contacts.

Delays in isolating cases by even one or two days, however, could hamper control of an epidemic, according to research by Ira M. Longini, Jr., PhD and M. Elizabeth Halloran, MD, Sc, Emory professors of biostatistics and their colleagues Azhar Nizam and Yang Yang, Dr. Longini will present the research at the AAAS Annual Meeting in Seattle on February 14.

Although mass vaccination during or before a smallpox attack would result in fewer cases and deaths than would surveillance and containment, the researchers concluded that an increased rate of vaccine-related serious illness and death would offset the slightly lower number of smallpox illnesses and deaths, especially since no one knows when or where an intentional release of smallpox would take place. The scientists also concluded that even if a particular smallpox virus were altered to cause more serious, or hemorrhagic cases than the ordinary virus, surveillance and containment would still be effective, although more deaths would occur.

In an earlier study (Science, Nov. 15 2002), the researchers concluded that targeted vaccination of the close contacts of infected individuals during a smallpox outbreak following a small attack could rival the effectiveness of mass vaccination, given a sufficiently high level of immunity within the population. However, as of May, 2003, fewer than 35,000 people had been newly vaccinated against smallpox, and many states had temporarily halted their smallpox vaccination programs. Although routine smallpox vaccinations were stopped in 1972, re
'"/>

Contact: Tia Webster
twebste@emory.edu
404-727-5692
Emory University Health Sciences Center
14-Feb-2004


Page: 1 2 3

Related biology news :

1. Protecting the Beat Of Life: Test Center Studies Interaction Between Pacemakers & Electronic Article Surveillance Systems
2. Hopkins Engineering Undergrads Inventions: Power Tools For Double Amputee, Military Surveillance Robot
3. Conserving hydrocarbons would save $438 billion
4. Sediment samples suggest how plants would fare in hotter, drier future
5. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
6. Endurance exercise found to be equally effective as diuretics in improving cardiac health
7. Purdue yeast makes ethanol from agricultural waste more effectively
8. Scientists learn how adjuvant makes vaccines effective
9. Super-effective jumping gene created
10. Drug combo effective in advanced breast cancer
11. Data show investigational antibiotic safe, effective in preventing travelers diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is pleased ... received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of ... Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform ...
Breaking Biology Technology:
Cached News: